| Oral Communication | Results from COG0201: a Randomized, Placebo-controlled, Double-blind, International, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Adults with Mild-to-Moderate Alzheimer’s Disease October 29, 2024, 5:55 PM local time Download Communication PDF |
| Poster Presentation | SHIMMER: Baseline Data and Early Lessons from the Ongoing Phase 2 Signal-finding Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies (DLB) Clinical Trials – Methodology: October 29-30, 2024 Download Presentation PDF |
Clinical Trials on Alzheimer’s Disease conference (CTAD)
October 29, 2024